HUTRIGEL
LIVE

Serial Number

79294494

Owner

HLB CELL CO., LTD

Attorney

Kisuk Lee

Filing Date

May 26, 2020

Add to watchlist:

No watchlists yet
View on USPTO

HUTRIGEL Trademark

Serial Number: 79294494 • Registration: 6450980

HUTRIGEL is a trademark filed by HLB CELL CO., LTD on May 26, 2020. The trademark is classified under Class 1 (Chemicals), Class 5 (Pharmaceuticals). The application is currently registered and active.

Owner Contact Info

HLB CELL CO., LTD (2 trademarks)

8F, Dongtan M Tower, 51-9,

Entity Type: 99

Trademark Details

Filing Date

May 26, 2020

Registration Date

August 17, 2021

Published for Opposition

June 1, 2021

Goods & Services

Pharmaceutical preparations for skin care; drug delivery agents in the form of solution, gel, and powder that facilitate the delivery of pharmaceutical preparations; medicament formulating agents for promoting wound healing of damaged epithelial tissues, connective tissues, nervous tissues, or dental tissues; biological preparations for medical or veterinary purposes, namely, for the treatment of traumatic wound, burn, ulcer, corneal diseases, mucosal and submucosal injuries, nerve injuries, internal organ injuries, tendon and ligament injuries, or dental diseases; culture media for medical use; biotechnological preparations for medical purposes, namely, biotechnologically-formed proteins for the treatment of traumatic wound, burn, ulcer, corneal diseases, mucosal and submucosal injuries, nerve injuries, internal organ injuries, tendon and ligament injuries, or dental diseases; cellular function activating agents for medical purposes; Medicated skin care preparations for medical purposes; collagen for medical purposes; pharmaceutical compositions, namely, pharmaceutical preparations for promoting wound healing of damaged epithelial tissues, connective tissues, nervous tissues, or dental tissues; surgical implants comprised of living tissues; Natural biomaterials for tissue restoration for medical purposes; implants comprising living tissue for guided tissue regeneration; implantable materials comprising living tissue for use in guided tissue regeneration; surgical implants comprising living tissues, namely, stem cells; extracellular matrix, namely, type 4 collagen, and laminin for medical purposes; Bone void fillers consisting of biological materials for medical purposes; biological preparations for medical purposes, namely, for the treatment of traumatic wound, burn, ulcer, corneal diseases, mucosal and submucosal injuries, nerve injuries, internal organ injuries, tendon and ligament injuries, or dental diseases; biological tissue cultures for medical purposes; biological tissue culture media for medical purposes

Cell growth media for growing cells for use in scientific and research use; biological preparations for scientific or laboratory purposes other than for medical or veterinary use; reagents for scientific purposes; chemical preparations for scientific purposes other than for medical or veterinary use; biological preparations for use in biotechnological product development other than medical or veterinary use; biochemicals for in vitro and in vivo scientific use; reagents for research purposes; reagents for medical research; collagen used as a raw ingredient in the manufacture of cosmetics; collagen peptides for cosmetics; collagen for use as a raw ingredient in the manufacture of cosmetics; protein for use in the manufacture of cosmetics; cells for scientific or laboratory purposes; biological preparations for scientific purposes, other than for medical or veterinary purposes; biological preparation for use in cell cultures other than for medical or veterinary use; biological material, namely, cell culture media for scientific and research use *, not for medical or veterinary purposes * ; Biological preparations, namely, extracellular matrix for cell cultures for use in scientific research *, not for medical or veterinary purposes * ; biological preparation, namely, type 4 collagen and laminin for bioprinting for industrial use *, not for medical or veterinary purposes * ; biological material for bioprinting, namely, type 4 collagen and laminin *, not for medical or veterinary purposes *

Filing History

INVALIDATION REVIEWED - NO ACTION REQUIRED BY OFFICE
Aug 18, 2022 INNA
PARTIAL INVALIDATION OF REG EXT PROTECTION CREATED
Jun 18, 2022 INPR
FINAL DECISION TRANSACTION PROCESSED BY IB
Feb 20, 2022 FINO
FINAL DISPOSITION NOTICE SENT TO IB
Jan 31, 2022 FICS
FINAL DISPOSITION PROCESSED
Jan 31, 2022 FIMP
FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB
Nov 17, 2021 FICR
LIMITATION FROM THE IB EXAMINED AND ENTERED
Oct 21, 2021 LIME
CASE ASSIGNED TO POST REGISTRATION PARALEGAL
Oct 18, 2021 APRE
CORRECTION UNDER SECTION 7 - PROCESSED
Oct 18, 2021 COC.
CASE ASSIGNED TO POST REGISTRATION PARALEGAL
Oct 18, 2021 APRE
LIMITATION OF GOODS RECEIVED FROM IB
Sep 19, 2021 LIMG
REGISTERED-PRINCIPAL REGISTER
Aug 17, 2021 R.PR
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Jun 1, 2021 NPUB
PUBLISHED FOR OPPOSITION
Jun 1, 2021 PUBO
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
May 12, 2021 NONP
APPROVED FOR PUB - PRINCIPAL REGISTER
Apr 23, 2021 CNSA
EXAMINER'S AMENDMENT ENTERED
Apr 23, 2021 XAEC
NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED
Apr 23, 2021 GNEN
EXAMINERS AMENDMENT E-MAILED
Apr 23, 2021 GNEA
EXAMINERS AMENDMENT -WRITTEN
Apr 23, 2021 CNEA
TEAS/EMAIL CORRESPONDENCE ENTERED
Apr 20, 2021 TEME
CORRESPONDENCE RECEIVED IN LAW OFFICE
Apr 20, 2021 CRFA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
Apr 20, 2021 TROA
APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED
Apr 20, 2021 CHAN
TEAS CHANGE OF CORRESPONDENCE RECEIVED
Apr 20, 2021 TCCA
ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Apr 20, 2021 ARAA
TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Apr 20, 2021 REAP
TEAS CHANGE OF OWNER ADDRESS RECEIVED
Apr 20, 2021 COAR
REFUSAL PROCESSED BY IB
Nov 14, 2020 RFNT
NON-FINAL ACTION MAILED - REFUSAL SENT TO IB
Oct 24, 2020 RFCS
REFUSAL PROCESSED BY MPU
Oct 24, 2020 RFRR
APPLICATION FILING RECEIPT MAILED
Oct 6, 2020 MAFR
NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW
Oct 2, 2020 RFCR
NON-FINAL ACTION WRITTEN
Oct 1, 2020 CNRT
ASSIGNED TO EXAMINER
Sep 30, 2020 DOCK
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Sep 30, 2020 NWOS
SN ASSIGNED FOR SECT 66A APPL FROM IB
Sep 24, 2020 REPR